Natera, Inc.
Jonathan Sheena (Director) sells NTRA shares
AI-generated summary
Jonathan Sheena, Director, CO-FOUNDER of Natera, Inc., sold 1,500 shares of common stock indirectly through trusts at an average price of $319.30 for a total value of $478,944.73 on November 11, 2026. Following these transactions, 7,500 shares were held indirectly by the Caraluna 2 Trust. The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on June 11, 2026.
Key facts
- Insider
- Jonathan Sheena · Director
Rule 10b5-1 plan · adopted Jun 11, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $315.26 | $12,610.40 | 8,210 | Indirect (by Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F3, F2 | −85 | $316.93 | $26,938.68 | 8,125 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F4, F2 | −145 | $317.87 | $46,091.85 | 7,980 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F5, F2 | −240 | $319.77 | $76,745.59 | 7,740 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F6, F2 | −160 | $320.02 | $51,203.01 | 7,580 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $322.00 | $12,880.00 | 7,540 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $323.06 | $12,922.60 | 7,500 | Indirect (By Caraluna 1 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $315.28 | $12,611.20 | 8,210 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F7, F2 | −48 | $317.33 | $15,231.61 | 8,162 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F8, F2 | −182 | $317.96 | $57,869.19 | 7,980 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F9, F2 | −240 | $319.22 | $76,612.01 | 7,740 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F10, F2 | −120 | $320.07 | $38,408.20 | 7,620 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F11, F2 | −80 | $322.88 | $25,830.00 | 7,540 | Indirect (By Caraluna 2 Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F2 | −40 | $324.76 | $12,990.40 | 7,500 | Indirect (By Caraluna 2 Trust) |
Footnotes
- F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
- F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
- F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
More NTRA filings
- 4
Filed Nov 10, 2026
- S-8
Filed Nov 10, 2026
- S-3ASR
Filed Nov 10, 2026
- SC 13G/A
Filed Nov 6, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.